A recent study suggests that people who stop using popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who halt conventional diet and exercise plans.
Published data in a leading health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using such treatments need to be aware of the danger of quick weight regain when the therapy ends," stated researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to starting mass within about one and a half years.
Analyzing Approaches
The study, which looked at dozens of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
The team point out that individuals who shed pounds through diet and exercise generally see a more gradual creep back—around 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Doctors propose the mode of action of the injections explains the accelerated regain.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk."
A Lifelong Condition?
Medical guidelines recommend the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, considering the likelihood of relapse, the treatment is often long-term.
This opinion is reinforced by drug manufacturers, who say that the results "emphasize the chronic character of excess weight," similar to managing diseases like hypertension.
User Accounts
Individuals who have stopped the jabs explain a sudden return of cravings.
"It felt as if a switch that goes on and you're instantly ravenous," recalled an individual.
The struggle is compounded if users have not established permanent lifestyle or habit changes during therapy.
Widespread Use
Recent estimates show that millions of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Adoption is more common among females than males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, clinicians stress that while the jabs are potent tools for shedding pounds, they are not a permanent fix and maintained weight loss hinges on combined behavioural support.
